Epion Medical Communications, LLC can help you create the medical content you need.
I work with medical communications companies, academic institutes, and web-based education companies to EDUCATE, PROMOTE and INFORM.
Find out how I can help you
​
TESTIMONIALS
"Rebecca has met every deadline while exceeding expectations due to her attention to detail and thoughtful analysis of complex clinical data. She is enthusiastic, collegial, and easy to work with throughout a project life-cycle, even in the face of client introduced project delays."
~Katherine E. Trueblood, PhD, CMPP
Associate Director, Strategic Scientific Communications
Nexus GG Science, LLC
"It has been a pleasure working with you on this project. You are fast, responsive and a great writer."
~Claire Astle
Communications Lead
BPOG - BioPhorum Operations Group
RECENT WORK
Maximum tolerated dose approaches have been the standard of care and the basis of clinical trials for decades. New research based on evolutionary principles suggests that this approach may not be the most effective for all tumor types.
Data from an early phase clinical trial shows that the combination of XL888, a heat shock protein 90 inhibitor, and vemurafenib, a BRAF inhibitor, in advanced melanoma patients is safe and has promising activity.
